![]() |
市场调查报告书
商品编码
1388279
内视镜黏膜下剥离市场 - 按产品(刀、胃镜和结肠镜、注射剂、抓握器/夹子、组织牵开器)、按应用(胃、结肠、食道)、按最终用途(医院、ASC) - 全球预测,2023年- 2032Endoscopic Submucosal Dissection Market - By Product (Knives, Gastroscopes & Colonoscopes, Injection Agents, Graspers/Clips, Tissue Retractors), By Application (Stomach, Colon, Esophageal), By End-use (Hospitals, ASCs) - Global Forecast, 2023-2032 |
由于全球胃癌盛行率不断上升,内视镜黏膜下剥离术市场规模预计从 2023 年到 2032 年将以 6.3% 的CAGR扩大。最近,一些国家,特别是亚洲和美洲的胃癌盛行率不断上升,进一步推动了对内视镜黏膜下剥离术(ESD)作为重要治疗方式的需求。根据美国癌症协会对 2022 年的估计,胃癌占美国每年所有新病例的 1.5%。由于 ESD 能够精确定位和消除早期胃肿瘤,同时保留器官功能,因此它也成为一种高度首选的治疗选择。
此外,具有更好成像能力的创新内视镜工具以及具有增强 ESD 手术有效性和安全性的精密仪器的推出将有助于市场扩张。例如,2023 年 1 月,富士软片印度公司宣布推出 ClutchCutter 和 FushKnife,协助临床医生在消化道内进行有效的内视镜黏膜下剥离术介入。
内视镜黏膜下剥离术产业分为产品、应用、最终用途和地区。
根据产品,胃镜和大肠镜领域的市场份额预计从 2023 年到 2032 年将达到 6.2% 的CAGR。胃镜和大肠镜设备对胃肠道疾病进行微创手术的需求量很大,因为它们在 ESD 手术期间提供高解析度成像和精确控制,以获得更好的诊断和治疗结果。此外,全球医疗保健系统对早期检测和介入的日益重视将推动该细分市场的成长。
根据应用,到 2032 年,食道癌领域的内视镜黏膜下剥离产业预计CAGR为5.9%。针对食道病变和早期癌症的ESD 手术由于其微创性质和保留器官的能力而变得越来越普遍功能。人们对食道疾病的广泛认识和诊断能力的提高也大大增加了对食道应用量身定制的复杂内视镜工具的需求。
从地区来看,由于胃肠道疾病盛行率上升以及对微创手术的日益关注,亚太地区内视镜黏膜下剥离术产业预计在2023年至2032年间呈现7.2%的成长率。由于胃癌发生率高,日本和韩国等国家正努力建立ESD实践。此外,医疗保健基础设施的不断进步、患者意识的提高以及人口老化的加剧将增强行业前景。
Endoscopic Submucosal Dissection Market size is estimated to expand at 6.3% CAGR from 2023-2032, driven by the increasing prevalence of gastric cancer globally. Of late, several nations, particularly in Asia and America are recording elevated rates of gastric cancer prevalence, further driving the demand for endoscopic submucosal dissection (ESD) as a vital treatment modality. According to the American Cancer Society's estimates for 2022, stomach cancer accounts for 1.5% of all new cases in the U.S. each year. ESD has also emerged as a highly preferred treatment option given its ability to precisely target and eliminate early-stage gastric tumors while preserving organ function.
Moreover, the introduction of innovative endoscopic tools with better imaging capabilities, and precision instruments with enhanced effectiveness and safety of ESD procedures will contribute to the market expansion. For instance, in January 2023, FUJIFILM India, announced the launch of ClutchCutter and FushKnife to assist aid clinicians in performing effective endoscopic submucosal dissection interventions within the digestive tract.
The endoscopic submucosal dissection industry is segmented into product, application, end-use, and region.
Based on product, the market share from the gastroscopes and colonoscopes segment is expected to attain 6.2% CAGR from 2023-2032. Gastroscopes and colonoscope devices are recording high demand to perform minimally invasive procedures for gastrointestinal disorders as they provide high-resolution imaging and precise control during ESD procedures for better diagnostic and therapeutic outcomes. Furthermore, the increasing emphasis on early detection and intervention by healthcare systems globally will propel the segment growth.
As per application, the endoscopic submucosal dissection industry from the esophageal cancer segment is estimated to depict 5.9% CAGR through 2032. ESD procedures for esophageal lesions and early-stage cancers have become increasingly prevalent due to their minimally invasive nature and the ability to preserve organ function. The widespread awareness of esophageal disorders and improving diagnostic capabilities is also surging the demand for sophisticated endoscopic tools tailored for esophageal applications.
Regionally, the Asia Pacific endoscopic submucosal dissection industry is poised to exhibit 7.2% growth rate between 2023 and 2032 owing to the rising prevalence of gastrointestinal diseases coupled with the growing focus on minimally invasive procedures. Countries, such as Japan and South Korea are working on establishing ESD practices due to the high incidence of gastric cancer. Moreover, the growing advancements in healthcare infrastructure, increasing patient awareness, and the rising aging population will augment the industry outlook.